[go: up one dir, main page]

BR9710544A - Composite treatment method and pharmaceutical composition - Google Patents

Composite treatment method and pharmaceutical composition

Info

Publication number
BR9710544A
BR9710544A BR9710544A BR9710544A BR9710544A BR 9710544 A BR9710544 A BR 9710544A BR 9710544 A BR9710544 A BR 9710544A BR 9710544 A BR9710544 A BR 9710544A BR 9710544 A BR9710544 A BR 9710544A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
treatment method
composite treatment
composite
pharmaceutical
Prior art date
Application number
BR9710544A
Other languages
Portuguese (pt)
Inventor
Argyrios Georgious Arvanitis
Robert John Chorvat
Paul Joseph Gilligan
Liqui He
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Priority claimed from PCT/US1997/013072 external-priority patent/WO1998003510A1/en
Priority claimed from US08/899,242 external-priority patent/US6124289A/en
Publication of BR9710544A publication Critical patent/BR9710544A/en

Links

BR9710544A 1996-07-24 1997-07-23 Composite treatment method and pharmaceutical composition BR9710544A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2329096P 1996-07-24 1996-07-24
US68604796A 1996-07-24 1996-07-24
PCT/US1997/013072 WO1998003510A1 (en) 1996-07-24 1997-07-23 AZOLO TRIAZINES AND PYRIMIDINES
US08/899,242 US6124289A (en) 1996-07-24 1997-07-23 Azolo triazines and pyrimidines

Publications (1)

Publication Number Publication Date
BR9710544A true BR9710544A (en) 1999-08-17

Family

ID=27362048

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9710544A BR9710544A (en) 1996-07-24 1997-07-23 Composite treatment method and pharmaceutical composition

Country Status (15)

Country Link
JP (2) JP4704521B2 (en)
CN (3) CN1104432C (en)
AR (1) AR049583A2 (en)
BR (1) BR9710544A (en)
CA (1) CA2259583C (en)
CZ (1) CZ299451B6 (en)
EA (1) EA004403B1 (en)
EE (1) EE04316B1 (en)
HR (1) HRP970413A2 (en)
IL (4) IL127871A0 (en)
NO (1) NO315610B1 (en)
NZ (1) NZ333777A (en)
PL (1) PL195762B1 (en)
SI (1) SI9720045B (en)
SK (1) SK286461B6 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030125330A1 (en) * 2001-03-13 2003-07-03 Gilligan Paul J. 4 - (2-butylamino) - 2, 7-dimethyl-8- (2-methyl-6-methoxypyrid-3-yl) pyrazolo- [1,5-A] - 1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
WO2004110454A1 (en) * 2003-06-13 2004-12-23 Ishihara Sangyo Kaisha, Ltd. COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST
US7329662B2 (en) * 2003-10-03 2008-02-12 Hoffmann-La Roche Inc. Pyrazolo-pyridine
GB0519957D0 (en) * 2005-09-30 2005-11-09 Sb Pharmco Inc Chemical compound
AU2007297421B2 (en) * 2006-09-20 2012-03-08 Eli Lilly And Company Thiazole pyrazolopyrimidines as CRF1 receptor antagonists
CN103694242B (en) * 2013-12-10 2016-01-06 昆明翔昊科技有限公司 Pyrazolopyrimidines and pharmaceutical composition thereof and its application in pharmacy
CN110996943A (en) 2017-08-14 2020-04-10 云杉生物科学公司 corticotropin-releasing factor receptor antagonists
CN112500416B (en) * 2019-07-30 2021-12-17 厦门宝太生物科技股份有限公司 Preparation method of pyrazolotriazine compound intermediate
KR20240023691A (en) 2020-08-12 2024-02-22 스프루스 바이오사이언시스 인코포레이티드 Methods and compositions for treating polycystic ovary syndrome
US11708372B2 (en) 2021-11-19 2023-07-25 Spruce Biosciences, Inc. Crystalline composition of tildacerfont and methods of use and preparation thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3995039A (en) * 1975-05-27 1976-11-30 Merck & Co., Inc. Pyrazolo [1,5-a] [1,3,5] triazines
JPS6157587A (en) * 1984-08-29 1986-03-24 Shionogi & Co Ltd Condensed heterocyclic derivative and antiulcerative
US4824834A (en) * 1986-10-31 1989-04-25 Otsuka Pharmaceutical Company, Limited Pyrazolotriazine compounds
JP2691317B2 (en) * 1989-08-25 1997-12-17 株式会社大塚製薬工場 4-Hydroxy-8- (3-lower alkoxy-4-phenylsulfinylphenyl) pyrazolo [1,5-a] -1,3,5-triazine optically active salts and process for producing the same
EP0503099A4 (en) * 1990-10-09 1993-12-01 Otsuka Pharmaceutical Co., Ltd. Pyrimidine derivative, production thereof, and androgen inhibitor
KR100191774B1 (en) * 1991-04-22 1999-06-15 오스카 아끼히꼬 Pyrazolo [1,5-alpha] pyrimidine derivatives and anti-inflammatory agents containing them
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines

Also Published As

Publication number Publication date
SI9720045B (en) 2008-02-29
NO315610B3 (en) 2003-09-29
IL127871A0 (en) 1999-10-28
CA2259583A1 (en) 1998-01-29
NO990264L (en) 1999-03-10
NZ333777A (en) 2000-07-28
HRP970413A2 (en) 1998-10-31
CZ299451B6 (en) 2008-07-30
CA2259583C (en) 2009-11-17
CN1225637A (en) 1999-08-11
EA199900158A1 (en) 1999-10-28
CZ18499A3 (en) 1999-11-17
JP2005097257A (en) 2005-04-14
IL164513A0 (en) 2005-12-18
EE9900019A (en) 1999-08-16
NO315610B1 (en) 2003-09-29
CN1327793A (en) 2001-12-26
AR049583A2 (en) 2006-08-16
EA004403B1 (en) 2004-04-29
CN1104432C (en) 2003-04-02
JP2002513382A (en) 2002-05-08
SK286461B6 (en) 2008-10-07
NO990264D0 (en) 1999-01-21
SI9720045A (en) 1999-10-31
JP4704521B2 (en) 2011-06-15
IL127871A (en) 2010-04-29
CN1250223C (en) 2006-04-12
EE04316B1 (en) 2004-06-15
CN1388126A (en) 2003-01-01
PL331523A1 (en) 1999-07-19
PL195762B1 (en) 2007-10-31
JP4194539B2 (en) 2008-12-10
SK9799A3 (en) 2005-04-01
IL164513A (en) 2010-04-29
IL150163A (en) 2010-12-30

Similar Documents

Publication Publication Date Title
BR9407799A (en) Composition of matter treatment method and pharmaceutical composition
BR9609132A (en) Seed composition and treatment method
DE69737795D1 (en) COMPOSITE COMPONENT AND WALL CONSTRUCTION PROCESS
FI972164L (en) Aerogel-containing composite material, method for its preparation and use
FI972165L (en) Aerogel-containing composite material, method for its preparation and use
DE69721286D1 (en) FASTENING DEVICE AND APPLICATION METHOD THEREFOR
EE9800234A (en) Method of treatment and pharmaceutical composition
EE04681B1 (en) 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition
FI951060L (en) Formulations and treatment methods
FI964869L (en) Location method and system
BR9710379A (en) Decorative titanium material and hardening method for the same
FI972235L (en) Method for using triarylethylene derivatives in the treatment and prevention of osteoporosis
BR9509688A (en) Pharmaceutical composition and composition
BR9710544A (en) Composite treatment method and pharmaceutical composition
PT932400E (en) DERIVATIVES OF USED ANTICONVULSIONERS IN THE TREATMENT OF NEUROPATIC PAIN
DE69514960D1 (en) Slag treatment system and method
FI972988A0 (en) Methods and pharmaceutical compositions using desmethylselegiline
BR9700362A (en) Intermediate cylinder set of srlo and conveyor system
DE69718502D1 (en) DENTAL COMPOSITION, SYSTEM AND METHOD
FR2746261B1 (en) INSECTICIDE COMPOSITION AND PREPARATION METHOD
BR9707332A (en) Double curing coating method and formulation
FI953391L (en) Composite material, method for its preparation and use
ID19437A (en) PROCESSING AND COMPOSITION FOR ANTI-PARASIT TREATMENT AROUND ANIMAL PLACES
BR9612503A (en) Self-initialized encoder and method
DE69524527D1 (en) AIDS-inhibiting drug preparation and method

Legal Events

Date Code Title Description
TE Change of address
B25D Requested change of name of applicant approved
B25G Requested change of headquarter approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO, UMA VEZ QUE ESTE NAO ATENDE AOS ARTIGOS 24 E 25 DA LEI 9.279/96

B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]